Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about JP:4523
Recent news which mentions JP:4523
Merck and Eisai say two lung-cancer trials failed to meet their main goals
September 22, 2023
Tickers
ESAIY
SPX
Tags
ESAIY
SPX
JP:4523
From
MarketWatch
Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
June 07, 2023
Tags
JP:4523
From
MarketWatch
New Alzheimer’s drug could bring hope to patients, but could be out of reach for people on Medicare
May 25, 2023
Tickers
BIIB
Tags
BIIB
JP:4523
From
MarketWatch
Eli Lilly’s positive results from a Alzheimer’s trial seen as ‘potentially very important’
May 03, 2023
Tickers
BIIB
LLY
Tags
LLY
JP:4523
BIIB
From
MarketWatch
Healthcare merger mania scrutinized on Capitol Hill as new deal combines major health systems
April 26, 2023
Tickers
BIIB
Tags
BIIB
JP:4523
From
MarketWatch
Veterans Health Administration will cover new Alzheimer’s drug. Why won’t Medicare?
March 22, 2023
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
Wall Street predicts approval for another ALS drug
March 21, 2023
Tickers
AMLX
BIIB
IONS
Tags
JP:4523
IONS
BIIB
From
MarketWatch
Medicare just crushed the hopes of 750,000 Alzheimer’s patients a year
March 03, 2023
Tickers
BIIB
SPX
Tags
BIIB
JP:4523
RUT
From
MarketWatch
FDA approves Reata’s rare disease drug amid questions about changes to the regulatory environment for neuroscience treatments
February 28, 2023
Tickers
BIIB
EWTX
RETA
SPX
Tags
RETA
EWTX
XPH
From
MarketWatch
New Alzheimer’s drug shows some promise, but has big price tag
February 02, 2023
Tickers
BIIB
ESALF
Tags
BIIB
JP:4523
ESALF
From
MarketWatch
Why the FDA didn’t grant an approval to Lilly’s Alzheimer’s drug
January 20, 2023
Tickers
BIIB
LLY
SPX
Tags
LLY
JP:4523
BIIB
From
MarketWatch
Amid criticism for its handling of another Alzheimer’s drug, FDA will decide this week whether to approve lecanemab
January 03, 2023
Tickers
BIIB
LLY
Tags
JP:4523
LLY
BIIB
From
MarketWatch
New Alzheimer’s drug appears to slow cognitive decline but is ‘not a breakthrough’
December 09, 2022
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
5 things to know about the new Alzheimer’s drug — including why it may be risky for people who take blood thinners
November 30, 2022
Tickers
BIIB
SPX
Tags
BIIB
JP:4523
SPX
From
MarketWatch
Banks are short more than $1 trillion in capital, this analyst says, who fears the shortfall will only get worse
November 30, 2022
Tickers
AMC
AMGN
APE
BABA
Tags
NQ00
HZNP
GME
From
MarketWatch
A new Alzheimer’s treatment may help some patients, though researchers say more safety data is needed
November 29, 2022
Tickers
BIIB
Tags
BIIB
JP:4523
From
MarketWatch
Eisai shares fall following report of patient death in Alzheimer’s trial
November 28, 2022
Tickers
BIIB
Tags
BIIB
JP:4523
From
MarketWatch
What to know about the Alzheimer’s drug data coming out this week
November 28, 2022
Tickers
AXSM
BIIB
LLY
MOR
Tags
LLY
CH:ROG
AXSM
From
MarketWatch
One Alzheimer’s drug has failed, but investors are still betting on Biogen and Lilly treatments
November 14, 2022
Tickers
BIIB
ESALF
LLY
MOR
Tags
PRTA
ESALF
CH:ROG
From
MarketWatch
Biogen and Eisai make plans to take another Alzheimer’s drug to the FDA
October 25, 2022
Tickers
BIIB
SPX
Tags
BIIB
JP:4523
SPX
From
MarketWatch
Medicare coverage of Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
September 28, 2022
Tickers
BIIB
ESALF
SPX
Tags
SPX
ESALF
BIIB
From
MarketWatch
Here’s why one strategist says the consumer and related stocks might get a second wind
September 28, 2022
Tickers
AAPL
AMC
AMZN
APE
Tags
BX:TMUBMUSD02Y
DXY
DWAC
From
MarketWatch
Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
September 28, 2022
Tickers
BIIB
LLY
Tags
LLY
JP:4523
BIIB
From
MarketWatch
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
September 28, 2022
Tickers
BIIB
ESALY
Tags
BIIB
JP:4523
JP:NIK
From
MarketWatch
Alzheimer’s drug from Eisai, Biogen shows promise in large trial
September 27, 2022
Tickers
BIIB
Tags
JP:4523
BIIB
From
MarketWatch
Eisai shares sink after Japan regulators seek more data for review of Alzheimer’s drug
December 22, 2021
Tickers
BIIB
Tags
BIIB
JP:4523
From
MarketWatch
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit